España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
23andMe Holding
ME
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.10
-0.31
-9.09%
At close: -
$3.32
0.22
7.09%
After Hours: Jan 31, 6:42 PM EDT
Get Report
Comment
Q3 2025 Earnings were released on Tue Jan 28th, after the market close
23andMe Holding (ME) Forecast
News
Earnings
23andMe Holding (ME) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for 23andMe Holding (NASDAQ:ME) Stock
23andMe Holding Stock (NASDAQ: ME)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 31, 2025
23andMe Holding Released New Polygenic Risk S...
Benzinga Newsdesk
Tuesday, January 28, 2025
Trading Halt: Halt status updated at 5:50:00 ...
Benzinga Newsdesk
23andMe Reveals Process To Explore Strategic ...
Benzinga Newsdesk
23andMe Notes Continued Concerns Regarding Li...
Benzinga Newsdesk
23andMe Holding Q3 2025 GAAP EPS From Cont Op...
Benzinga Newsdesk
Trading Halt: Halted at 5:10:00 p.m. ET - Tra...
Benzinga Newsdesk
Saturday, January 25, 2025
Deal Dispatch: Lovely Day To Sell Guinness? Plus, 23andMe To Rid Lineage Of Lemonaid
Anthony Noto
Wednesday, January 08, 2025
23andme Announced The Launch Of Discover23, A...
Lekha Gupta
Wednesday, November 20, 2024
23andMe And Mirador Therapeutics Announced A ...
Benzinga Newsdesk
Friday, November 15, 2024
23andMe shares are trading lower. The stock m...
Benzinga Newsdesk
Tuesday, November 12, 2024
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
Vandana Singh
23andMe Holding Q2 2025 GAAP EPS $(2.32), Sal...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
23andMe Discontinues Development Of Therapeut...
Benzinga Newsdesk
23andMe Plans Restructuring To Streamline Ope...
Benzinga Newsdesk
Earnings Outlook For 23andMe Holding
Benzinga Insights
Wednesday, October 30, 2024
23andMe Regains Compliance With Minimum Closi...
Benzinga Newsdesk
Friday, October 11, 2024
23andMe shares are trading lower. The company...
Benzinga Newsdesk
23andMe Announces 1-For-20 Reverse Stock Spli...
Benzinga Newsdesk
Wednesday, October 02, 2024
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
Vandana Singh
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, September 25, 2024
23andMe Holding Co Released A New Report On T...
Benzinga Newsdesk
Wednesday, September 18, 2024
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
Vandana Singh
General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, September 17, 2024
23andMe shares are trading lower after the in...
Benzinga Newsdesk
Independent Directors Of 23andMe Board Cited ...
Benzinga Newsdesk
23andMe Independent Directors Tendered Resign...
Benzinga Newsdesk
Monday, September 16, 2024
Reported Sunday, 23andMe Announced Nonclinica...
Benzinga Newsdesk
Reported Earlier, 23andMe Therapeutics Releas...
Benzinga Newsdesk
Thursday, August 29, 2024
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, August 28, 2024
Lemonaid Health Is Now Offering Ozempic, Wego...
Benzinga Newsdesk
Thursday, August 08, 2024
23andMe Holding Q1 2025 GAAP EPS $(0.14), Sal...
Benzinga Newsdesk
Friday, August 02, 2024
23andMe Special Committee Responds To CEO's T...
Benzinga Newsdesk
Thursday, August 01, 2024
23andMe Receives Preliminary Non-Binding Prop...
Benzinga Newsdesk
Thursday, July 25, 2024
23andMe In Collaboration With 20 Lung Cancer ...
Benzinga Newsdesk
Friday, June 28, 2024
23andMe And Nightingale Health Announced A St...
Benzinga Newsdesk
Wednesday, June 12, 2024
Looking Into 23andMe Holding's Recent Short Interest
Benzinga Insights
Monday, June 10, 2024
Canada Authority Says Canada And UK Privacy A...
Benzinga Newsdesk
Monday, June 03, 2024
23andMe Therapeutics Present Preliminary Phas...
Benzinga Newsdesk
Thursday, May 23, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
23andMe Holding shares are trading higher fol...
Benzinga Newsdesk
23andMe Board On Mar. 28 Formed Special Commi...
Benzinga Newsdesk
23andMe Holding Q4 2024 GAAP EPS $(0.43), Sal...
Benzinga Newsdesk
Tuesday, May 14, 2024
Petros Pharmaceuticals Launches U.S. Distribu...
Benzinga Newsdesk
Friday, May 10, 2024
23andMe Holding Granted Additional 180 Days, ...
Benzinga Newsdesk
Wednesday, April 24, 2024
23andMe To Present Preliminary Efficacy And B...
Benzinga Newsdesk
Thursday, April 18, 2024
Nasdaq Down 0.5%; Lithium Americas Shares Slide
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
Avi Kapoor
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
Vandana Singh
Show More
